# PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

> **NCT07327515** · NA · NOT_YET_RECRUITING · sponsor: **Li Min** · enrollment: 90 (estimated)

## Conditions studied

- Malignant Tumors

## Interventions

- **PROCEDURE:** CT-Guided Radioactive Seed Implantation
- **PROCEDURE:** PET/CT-Guided Radioactive Seed Implantation
- **PROCEDURE:** PET/CT-Guided Radioactive Seed Implantation (Biological Dose Optimization)
- **PROCEDURE:** Tumor-Specific PET/CT-Guided Radioactive Seed Implantation (PSMA/FAPI Subgroup)

## Key facts

- **NCT ID:** NCT07327515
- **Lead sponsor:** Li Min
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07327515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07327515, "PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07327515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*